Efficacy and Safety of Atomization Inhalation of Polymyxin in the Adjunctive Treatment of Ventilator-associated Pneumonia:A Meta-analysis / 中国药房
China Pharmacy
; (12): 2400-2405, 2021.
Article
in Zh
| WPRIM
| ID: wpr-886924
Responsible library:
WPRO
ABSTRACT
OBJECTIVE:To evaluate the efficacy and safety of atomization inhalation of polymyxin combined in the adjunctive treatment for ventilator-associated pneumonia ,and to provide evidence-based reference for clinical treatment. METHODS : Retrieved from Cochrane Library ,Embase,PubMed,Web of Science ,CNKI,CBM,VIP and Wanfang database (from their inception to March 2021),randomized controlled trials (RCTs)about efficacy and safety of atomization inhalation of polymyxin combined with conventional treatment (trial group ) versus conventional treatment (control group ) for ventilator- associated pneumonia were collected. After data extraction and quality evaluation of included literatures met inclusion and exclusion criteria , Meta-analysis was performed by using Rev Man 5.4 software. RESULTS :A total of 13 clinical studies were included ,involving 2 RCTs and 11 cohort studies with a total of 1 066 patients. The results of Meta-analysis showed that clinical response rate [OR = 1.53,95%CI(1.17,2.00),P=0.002],microbial clearance rate [OR =1.46,95%CI(1.11,1.91),P=0.007] of trial group were significantly higher than those of control group ,with statistical significance. There was no statistical significance in the mortality rate [OR =0.88,95%CI(0.68,1.14),P=0.32] and the incidence of renal impairment [OR =1.04,95%CI(0.72,1.49),P=0.85] between 2 groups. CONCLUSIONS :Based on current evidence ,atomization inhalation of polymyxin combined with conventional treatment can significantly improve clinical response rate and microbial clearance rate of patients with ventilator- associated pneumonia. However , more strictly-designed , long-term follow-up and large-scale RCTs are needed.
Full text:
1
Database:
WPRIM
Type of study:
Clinical_trials
/
Observational_studies
/
Systematic_reviews
Language:
Zh
Journal:
China Pharmacy
Year:
2021
Document type:
Article